Farnesyltransferase Inhibitors in Breast Cancer Therapy
- 1 January 2002
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 20 (sup2) , 30-37
- https://doi.org/10.1081/cnv-120014884
Abstract
Farnesyltransferase inhibitors (FTIs) belong to a group of agents originally designed to prevent membrane attachment of Ras protein by inhibiting a key step in its post-translational processing. It...Keywords
This publication has 48 references indexed in Scilit:
- Direct Interaction of SOS1 Ras Exchange Protein with the SH3 Domain of Phospholipase C-γ1Biochemistry, 2000
- Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude MiceJournal of Biological Chemistry, 2000
- The Regulation and Activities of the Multifunctional Serine/Threonine Kinase Akt/PKBExperimental Cell Research, 1999
- Induction of NF-κB by the Akt/PKB kinaseCurrent Biology, 1999
- Post-translational Modification of Human Brain Type I Inositol-1,4,5-trisphosphate 5-Phosphatase by FarnesylationPublished by Elsevier ,1996
- Aberrant function of the Ras signal transduction pathway in human breast cancerBreast Cancer Research and Treatment, 1995
- Receptor Protein-Tyrosine Kinases and Their Signal Transduction PathwaysAnnual Review of Cell and Developmental Biology, 1994
- Growth factors in breast cancer: Mitogenesis to transformationThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Growth factor signaling by receptor tyrosine kinasesNeuron, 1992
- Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanismEuropean Journal of Cancer and Clinical Oncology, 1991